PubMed · 6157147
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
A Gorman. 1980-07-31. Thalassaemia.. https://pubmed.ncbi.nlm.nih.gov/6157147/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
CONTEXT: Quantitation of hemoglobin (Hb) A(1c) and investigation of hemoglobinopathy on the Bio-Rad Variant analyzers require a switch between 2 separate kits that is time consuming and causes errors. OBJECTIVE: Evaluation of a new Variant II HbA(2)/HbA(1c) Dual kit capable of both Hb A(1c) quantitation and hemoglobinopathy investigation on a single kit. DESIGN: We evaluated Hb A(1c), Hb A(2), and Hb F quantitation for precision, linearity, and correlation with current methodology. We also evaluated detection of Hb variants and correlation of Hb Barts quantitation. SETTING: Hamilton Regional Laboratory Medicine Program, Provincial Hemoglobinopathy Laboratory, St Joseph's Healthcare Site, Hamilton, Ontario. PATIENTS: Patient blood samples submitted for Hb A(1c) quantitation or hemoglobinopathy investigation. MAIN OUTCOME MEASURES: Precision, linearity, linear regression, and reference interval validation. RESULTS: We provide tables and figures illustrating precision, linearity, linear regression, and quantitation of Hb variants. We validated reference intervals for Hb A(1c), Hb A(2), and Hb F. CONCLUSIONS: The dual kit provides precise Hb A(1c), Hb A(2), and Hb F quantitation. The results show good linearity and correlate well with the results of current methods. We detected all clinically important Hb variants and a wide variety of rare variants. The dual kit has several advantages: it eliminates the need for extensive kit switch over; improves utility for newborn screening because of its quantification of Hb Barts; permits quantification of Hb A(1c) using the beta-Thal method; and eliminates the need for separate Hb A(2) reference intervals for patients with Hb S because of its accurate quantitation of Hb A(2) in the presence of Hb S.
A simple, rapid method is presented for assessing the fetal hemoglobin fraction (%HbF). The principle of the measurement is straightforward. If two co-oximeters differ in the extent to which fetal hemoglobin interferes with their measurements of a particular analyte and if no other source of interference is present, then the magnitude of the difference in the HbF-induced interference between the two instruments can provide a quantitative measure of the fetal hemoglobin fraction. The present method does not require measuring optical absorbances at specific wavelengths or solving multiple simultaneous equations. On the contrary, the present method requires only one measurement on each instrument and a single simple calculation that yields a useful estimation of %HbF. Finally, it should be noted that this method can also be used for quantifying the concentrations of other compounds if two co-oximeters are available that differ appreciably in the extent to which the compound of interest interferes with their measurements of a particular analyte.
To determine the postnatal developmental changes in (G)gamma- and (A)gamma-globin mRNAs of HbF, blood samples were obtained from 28 pre-term infants born at < or = 33 weeks of gestation (27.9 +/- 2.5), 9 term-born infants and 26 adults. Adult samples were used to determine the relationship between the levels (G)gamma- and (A)gamma-mRNAs of HbF and the-158 (C-->T) variation in the promoter region of the (G)gamma-globin gene. The results showed that (G)gamma-globin mRNA to total gamma-globin mRNAs remained around 66% (66.2 +/- 4) until the 44 week of postconceptual age when a change in the (G)gamma- and (A)gamma-globin mRNA proportions occurred. The immature red cells of adults had a range of (G)gamma-globin mRNA to total gamma-globin mRNAs varying from 20 to 74% (53.1 +/- 16.9). The high levels of (G)gamma-globin mRNA to total gamma-globin mRNAs are associated with the presence of a -158 (C-->T) polymorphism. The gene frequency of polymorphism was 0.32.